Tim J Elliott

The paper identifies functional neoantigens in NSCLC patients using immunopeptidomics, achieving an 83% success rate in eliciting immune responses.

This study shows TMEM33 limits progenitor-exhausted CD8+ T cells, enhances anti-tumor responses, and correlates with improved survival in melanoma patients.

This study develops a peptide-exchange system to efficiently study KIR binding to HLA-I molecules with peptide specificity.

The paper investigates tapasin-independent peptide editing by MHC-I molecules using molecular dynamics simulations, revealing an 'active displacement' mechanism that explains peptide selection and immunogenic epitope presentation.

This study compares protein expression between oesophageal adenocarcinoma and normal adjacent tissue using proteomics to identify differentially expressed proteins and pathways.

The paper analyzes single-cell immune multi-omics data from PDAC to identify differential immunosuppressive mechanisms in distinct tumour microenvironments.

The paper compares transcriptomic and proteomic expression between two NSCLC subtypes to identify potential therapeutic targets and biomarkers.